Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Wealth planning strategies help safeguard and increase your assets. Discover the best methods to secure your financial future.
15,484 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Circle Internet Group sparked a strong move in the market as investors welcomed a robust quarterly report. This artic...
The Invesco S&P 500 Momentum ETF (SPMO) is again outperforming SPY on a trailing basis while showing resilience durin...
Yorkville America pulled Truth Social crypto ETF filings, signaling a pivot to the 40 Act structure. Analysts debate ...
A once-prolific $1,000 strategy beat the market story has turned into a cautionary tale. New investors face sharp los...
A transformative update could reshape Micron stock dynamics. This guide breaks down what the news might mean, how to ...
A momentum-driven small-cap ETF with about $2.2 billion in assets again outpaced major benchmarks, drawing investor a...
XRP holders can now earn yield from a native DeFi setup, as Flare and Xaman unveil a one-click integration. Two more ...
A conflict over Iran threatens Asia's access to fertilizer and helium, risking farm yields and semiconductor supply c...
CME marks a year since launching XRP futures, with notional volume around $63 billion as of mid-May 2026. The platfor...
As AI stocks drive gains, traders debate whether equal-weighted ETFs like RSP can outpace SPY’s cap-weighted edge. He...
Bitcoin has tumbled from its peak, leaving many investors unsure about the next move. This guide breaks down what the...